The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Xi, H.
Right arrow Articles by Kersh, G. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Xi, H.
Right arrow Articles by Kersh, G. J.
The Journal of Immunology, 2004, 173: 340-348.
Copyright © 2004 by The American Association of Immunologists

Sustained Early Growth Response Gene 3 Expression Inhibits the Survival of CD4/CD8 Double-Positive Thymocytes1

Hongkang Xi and Gilbert J. Kersh2

Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA 30322

In the absence of selection, CD4+, CD8+ double-positive (DP) thymocytes will die after 3–4 days. The mechanism for regulating the life span of DP cells is unknown. Previously, we demonstrated that the zinc finger transcription factor, early growth response gene 3 (Egr3), promotes proliferation during the transition from double negative (DN) to DP. In this study we demonstrate a novel role for Egr3 in controlling DP thymocyte survival in mice. Constitutive transgenic expression of Egr3 in thymocytes increases apoptosis among DP cells and shortens their survival in vitro. In addition, DP cells in Egr3 transgenic mice have poor expression of TCR{alpha}, and based on the predominant usage of 3' V{alpha} and 5' J{alpha} gene segments, the low level of TCR{alpha} expression is a result of DP death soon after the initiation of TCR{alpha} rearrangements. Constitutive transgenic expression of Egr3 results in poor expression of Bcl-xL and the thymic isoform of retinoic acid receptor-related orphan receptor {gamma} (ROR{gamma}t) in DP thymocytes, two molecules that are required in DP cells for normal life span. Egr3 expression induced by pre-TCR signals in nontransgenic mice is transient and returns to background levels before ROR{gamma}t or Bcl-xL is induced. The data support a model in which Egr3 must be transiently induced in response to pre-TCR signals, so that the expression of the prosurvival molecules, ROR{gamma}t and Bcl-xL, can be elevated only after the proliferative signal provided by Egr3 has subsided.




This article has been cited by other articles:


Home page
J. Immunol.Home page
J. H. Carter, J. M. Lefebvre, D. L. Wiest, and W. G. Tourtellotte
Redundant Role for Early Growth Response Transcriptional Regulators in Thymocyte Differentiation and Survival
J. Immunol., June 1, 2007; 178(11): 6796 - 6805.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
S. A. Lahousse, D. G. Wallace, D. Liu, K. W. Gaido, and K. J. Johnson
Testicular Gene Expression Profiling following Prepubertal Rat Mono-(2-ethylhexyl) Phthalate Exposure Suggests a Common Initial Genetic Response at Fetal and Prepubertal Ages
Toxicol. Sci., October 1, 2006; 93(2): 369 - 381.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. Xie, Z. Huang, M. S. Sadim, and Z. Sun
Stabilized {beta}-Catenin Extends Thymocyte Survival by Up-Regulating Bcl-xL
J. Immunol., December 15, 2005; 175(12): 7981 - 7988.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
X. Luo, L. Ding, J. Xu, R. S. Williams, and N. Chegini
Leiomyoma and Myometrial Gene Expression Profiles and Their Responses to Gonadotropin-Releasing Hormone Analog Therapy
Endocrinology, March 1, 2005; 146(3): 1074 - 1096.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.